{"id":"W2020779524","doi":"10.1358/dot.2004.40.10.863742","title":"Gefitinib: Current status in the treatment of non-small cell lungcancer","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Gefitinib; Medicine; Lung cancer; Tolerability; Oncology; Epidermal growth factor receptor; Internal medicine; Chemotherapy; Tyrosine-kinase inhibitor; Cancer; Adverse effect","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002615502,0.0009465958,0.001718549,0.001196231,0.0005173967,0.002382718,0.001114216,0.002321562,0.007337233],"category_scores_gemma":[0.002215478,0.0002681063,0.0005708702,0.00212421,0.001047089,0.003406018,0.0009776973,0.002522455,0.004721118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001258436,"about_ca_system_score_gemma":0.002600447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001067917,"about_ca_topic_score_gemma":0.002111793,"domain_scores_codex":[0.9993958,0.0001119268,0.000101434,0.0001114466,0.0001677409,0.000111583],"domain_scores_gemma":[0.9980166,0.0004579331,0.0003206745,0.000050429,0.0005525024,0.0006018815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005023279,0.0001328287,0.0005699021,0.003182165,0.0000432026,0.0001041409,0.00004994598,0.0002253496,0.001136122,0.001799831,0.04727717,0.9449771],"study_design_scores_gemma":[0.0001488033,0.0008169988,0.001962783,0.001441526,0.0001264208,0.0007358416,0.00005277041,0.000467894,0.0006719731,0.001225194,0.9923183,0.00003167226],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009040925,0.9906872,0.0003839835,0.004024921,0.001103022,0.00001996198,0.00008128887,0.00008409118,0.002711417],"genre_scores_gemma":[0.01223279,0.9763321,0.00109141,0.002857677,0.003302921,0.00006994385,0.0004947014,0.00003038476,0.003588143],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007337233,"threshold_uncertainty_score":0.02454555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03334470967723603,"score_gpt":0.3830884928690895,"score_spread":0.3497437831918535,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}